Highlights
The global Breast Lesion Localization market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Breast Lesion Localization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Breast Lesion Localization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Breast Lesion Localization in Tumor Identification is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Breast Lesion Localization include BD, Endomagnetics, SOMATEX Medical Technologies, Cook Medical, Cianna Medical, Leica Biosystems, Technologies GmbH, Argon Medical Devices, Inc. and CP Medical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Breast Lesion Localization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Lesion Localization.
The Breast Lesion Localization market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Breast Lesion Localization market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Lesion Localization companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BD
Endomagnetics
SOMATEX Medical Technologies
Cook Medical
Cianna Medical
Leica Biosystems
Technologies GmbH
Argon Medical Devices, Inc.
CP Medical
Sterylab
Segment by Type
Wire
Radioisotope
Magnetic
Segment by Application
Tumor Identification
Sentinel Lymph Node
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Lesion Localization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Breast Lesion Localization Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Wire
1.2.3 Radioisotope
1.2.4 Magnetic
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Breast Lesion Localization Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Tumor Identification
1.3.3 Sentinel Lymph Node
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Lesion Localization Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Breast Lesion Localization Growth Trends by Region
2.2.1 Global Breast Lesion Localization Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Breast Lesion Localization Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Breast Lesion Localization Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Breast Lesion Localization Âé¶¹Ô´´ Dynamics
2.3.1 Breast Lesion Localization Industry Trends
2.3.2 Breast Lesion Localization Âé¶¹Ô´´ Drivers
2.3.3 Breast Lesion Localization Âé¶¹Ô´´ Challenges
2.3.4 Breast Lesion Localization Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Lesion Localization Players by Revenue
3.1.1 Global Top Breast Lesion Localization Players by Revenue (2018-2023)
3.1.2 Global Breast Lesion Localization Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Breast Lesion Localization Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Lesion Localization Revenue
3.4 Global Breast Lesion Localization Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Breast Lesion Localization Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Lesion Localization Revenue in 2022
3.5 Breast Lesion Localization Key Players Head office and Area Served
3.6 Key Players Breast Lesion Localization Product Solution and Service
3.7 Date of Enter into Breast Lesion Localization Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Lesion Localization Breakdown Data by Type
4.1 Global Breast Lesion Localization Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Breast Lesion Localization Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Breast Lesion Localization Breakdown Data by Application
5.1 Global Breast Lesion Localization Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Breast Lesion Localization Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Breast Lesion Localization Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Breast Lesion Localization Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Lesion Localization Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Breast Lesion Localization Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Lesion Localization Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Breast Lesion Localization Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Breast Lesion Localization Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Breast Lesion Localization Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Lesion Localization Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Breast Lesion Localization Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Lesion Localization Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Breast Lesion Localization Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Breast Lesion Localization Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Breast Lesion Localization Introduction
11.1.4 BD Revenue in Breast Lesion Localization Business (2018-2023)
11.1.5 BD Recent Development
11.2 Endomagnetics
11.2.1 Endomagnetics Company Detail
11.2.2 Endomagnetics Business Overview
11.2.3 Endomagnetics Breast Lesion Localization Introduction
11.2.4 Endomagnetics Revenue in Breast Lesion Localization Business (2018-2023)
11.2.5 Endomagnetics Recent Development
11.3 SOMATEX Medical Technologies
11.3.1 SOMATEX Medical Technologies Company Detail
11.3.2 SOMATEX Medical Technologies Business Overview
11.3.3 SOMATEX Medical Technologies Breast Lesion Localization Introduction
11.3.4 SOMATEX Medical Technologies Revenue in Breast Lesion Localization Business (2018-2023)
11.3.5 SOMATEX Medical Technologies Recent Development
11.4 Cook Medical
11.4.1 Cook Medical Company Detail
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Breast Lesion Localization Introduction
11.4.4 Cook Medical Revenue in Breast Lesion Localization Business (2018-2023)
11.4.5 Cook Medical Recent Development
11.5 Cianna Medical
11.5.1 Cianna Medical Company Detail
11.5.2 Cianna Medical Business Overview
11.5.3 Cianna Medical Breast Lesion Localization Introduction
11.5.4 Cianna Medical Revenue in Breast Lesion Localization Business (2018-2023)
11.5.5 Cianna Medical Recent Development
11.6 Leica Biosystems
11.6.1 Leica Biosystems Company Detail
11.6.2 Leica Biosystems Business Overview
11.6.3 Leica Biosystems Breast Lesion Localization Introduction
11.6.4 Leica Biosystems Revenue in Breast Lesion Localization Business (2018-2023)
11.6.5 Leica Biosystems Recent Development
11.7 Technologies GmbH
11.7.1 Technologies GmbH Company Detail
11.7.2 Technologies GmbH Business Overview
11.7.3 Technologies GmbH Breast Lesion Localization Introduction
11.7.4 Technologies GmbH Revenue in Breast Lesion Localization Business (2018-2023)
11.7.5 Technologies GmbH Recent Development
11.8 Argon Medical Devices, Inc.
11.8.1 Argon Medical Devices, Inc. Company Detail
11.8.2 Argon Medical Devices, Inc. Business Overview
11.8.3 Argon Medical Devices, Inc. Breast Lesion Localization Introduction
11.8.4 Argon Medical Devices, Inc. Revenue in Breast Lesion Localization Business (2018-2023)
11.8.5 Argon Medical Devices, Inc. Recent Development
11.9 CP Medical
11.9.1 CP Medical Company Detail
11.9.2 CP Medical Business Overview
11.9.3 CP Medical Breast Lesion Localization Introduction
11.9.4 CP Medical Revenue in Breast Lesion Localization Business (2018-2023)
11.9.5 CP Medical Recent Development
11.10 Sterylab
11.10.1 Sterylab Company Detail
11.10.2 Sterylab Business Overview
11.10.3 Sterylab Breast Lesion Localization Introduction
11.10.4 Sterylab Revenue in Breast Lesion Localization Business (2018-2023)
11.10.5 Sterylab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BD
Endomagnetics
SOMATEX Medical Technologies
Cook Medical
Cianna Medical
Leica Biosystems
Technologies GmbH
Argon Medical Devices, Inc.
CP Medical
Sterylab
Ìý
Ìý
*If Applicable.